Mayo bounces back in biotech
Sunday 26 February 2006
Celtic Pharma, based in Bermuda but with offices in London and New York, is the only fund of its kind that focuses on buying drugs rather than companies. The firm trawls cash-starved biotech companies for promising late-stage drugs that it intends to shepherd through clinical development. The firm hopes that once the drugs get to approval it will be ableto sell them to big pharmaceutical groups.
"There is a capital drought in the biotech sector and a pipeline problem in the pharma sector," said Mr Mayo, the joint founder. "We're basically arbitraging those two conditions."
Mr Mayo, a former banker, helped demerge Zeneca from ICI and then moved to Marconi, where he led a disastrous acquisition spree. The other founder is Stephen Evans-Frekes, who sold his biotech company, Sugen, to Pharmacia, now Pfizer, for $720m in 1999.
Celtic expects to close its first $500m fund next month, and then plans to raise $500m in mezzanine funds to bring its available cash to $1bn.
Since June, the company has accumulated a portfolio of eight drugs and plans to acquire up to 20 in total. "Measured in that way, it would make us one of the biggest pharmaceutical companies in the world," said Mr Mayo.
The firm's first drug due for approval is a pain-relieving gel for osteoarthritis sufferers. Celtic says it could replace the $5bn in sales that evaporated after Merck's Vioxx was withdrawn and others in its class, such as Celebrex, were forced to add strong warnings to their labels.
The drug's approval in Switzer- land is expected next year and approval in major markets would come in 2008.
World Beard and Moustache Championships held last week
- 1 'Nasa Confirms Six Days of Darkness in December': No, they don't - it's a hoax
- 2 Number of global billionaires has doubled since the financial crisis
- 3 Kentucky gang rape: 15-year-old boy left in critical condition after sexual attack by group at party
- 4 Of course, teenage girls need role models – but not like beauty vlogger Zoella
- 5 North Korean officials 'publicly executed for watching South Korean soap operas'
'Nasa Confirms Six Days of Darkness in December': No, they don't - it's a hoax
Canadian actor punched in face after 'Islamophobia' experiment goes wrong in wake of Ottawa shooting
Number of global billionaires has doubled since the financial crisis
Elizabeth Norment dead: House of Cards actress honoured by Kevin Spacey after she dies aged 61
Kentucky gang rape: 15-year-old boy left in critical condition after sexual attack by group at party
Pope Francis declares evolution and Big Bang theory are real and God is not 'a magician with a magic wand'
Huge surge in Ukip support after EU funding row, according to new poll
Ukip ‘exploiting grooming scandal’ to secure party’s first police chief
Nigel Farage: 'There’s nothing wrong with white people blacking up'
Muslims, immigration and teenage pregnancy: British people are ignorant about almost everything
Nigel Farage and Frankie Boyle clash over Andrew Lawrence's 'Mock the Week' criticism
iJobs Money & Business
£20000 - £23250 Per Annum pro rata: Clearwater People Solutions Ltd: Pro rata ...
£40 - 48k + Benefits: Guru Careers: We are seeking a Marketing Manager to join...
£45,000 - £65,000: Saxton Leigh: Our client is a well-known APAC Corporate and...
£60000 per annum: Ashdown Group: Compensation and Benefits Manager - Compensat...